triamcinolone has been researched along with Malignant Melanoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Aung, PP; Curry, JL; Duke, TC; Glitza Oliva, IC; Ledesma, DA; Marques-Piubelli, ML; Nagarajan, P; Nelson, KC; Prieto, VG; Tetzlaff, MT; Torres-Cabala, CA; Wistuba, II | 1 |
Kaufman, H; Lazarus, M | 1 |
KAUFMAN, HE | 1 |
Fidler, IJ; Lieber, S | 1 |
2 review(s) available for triamcinolone and Malignant Melanoma
Article | Year |
---|---|
An association between corticosteroid use and melanoma recurrence: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Aged; Carcinoma in Situ; Carcinoma, Basal Cell; Humans; Keloid; Male; Melanoma; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Skin Neoplasms; Triamcinolone | 2012 |
THE UVEA.
Topics: Anatomy; Arthritis; Autoantibodies; Betamethasone; Dexamethasone; Dihydroxyphenylalanine; Epidemiology; Histoplasmosis; Hypersensitivity; Melanoma; Mercaptopurine; Oxyphenbutazone; p-Methoxy-N-methylphenethylamine; Phenothiazines; Physiology; Prednisolone; Prednisone; Sarcoidosis; Toxicology; Toxoplasmosis; Triamcinolone; Uvea; Uveitis; Virus Diseases | 1964 |
2 other study(ies) available for triamcinolone and Malignant Melanoma
Article | Year |
---|---|
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.
Topics: Acitretin; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dermatitis; Drug Eruptions; Drug Therapy, Combination; Exportin 1 Protein; Female; Fluocinonide; Glucocorticoids; Humans; Hypertrophy; Immune Checkpoint Inhibitors; Karyopherins; Keratolytic Agents; Lichenoid Eruptions; Melanoma; Programmed Cell Death 1 Receptor; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Triamcinolone | 2020 |
Quantitative analysis of the mechanism of glucocorticoid enhancement of experimental metastasis.
Topics: Animals; Cell Transformation, Neoplastic; Cells, Cultured; Glucocorticoids; Iodine Isotopes; Lung; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Time Factors; Triamcinolone; Uracil | 1972 |